Annual accounts receivable:
$173.03M+$133.37M(+336.33%)Summary
- As of today (August 18, 2025), ASND annual accounts receivable is $173.03 million, with the most recent change of +$133.37 million (+336.33%) on December 31, 2024.
- During the last 3 years, ASND annual accounts receivable has risen by +$170.54 million (+6846.32%).
- ASND annual accounts receivable is now at all-time high.
Performance
ASND Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$129.65M+$57.62M(+79.99%)Summary
- As of today (August 18, 2025), ASND quarterly accounts receivable is $129.65 million, with the most recent change of +$57.62 million (+79.99%) on June 1, 2025.
- Over the past year, ASND quarterly accounts receivable has increased by +$76.96 million (+146.07%).
- ASND quarterly accounts receivable is now -24.70% below its all-time high of $172.18 million, reached on December 31, 2024.
Performance
ASND Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ASND Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +336.3% | +146.1% |
| 3 y3 years | +6846.3% | +2738.6% |
| 5 y5 years | +10000.0% | - |
ASND Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +6846.3% | -24.7% | +2738.6% |
| 5 y | 5-year | at high | >+9999.0% | -24.7% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -24.7% | >+9999.0% |
ASND Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $129.65M(+80.0%) |
| Mar 2025 | - | $72.03M(-58.2%) |
| Dec 2024 | $173.03M(+336.3%) | $172.18M(+366.1%) |
| Sep 2024 | - | $36.94M(-29.9%) |
| Jun 2024 | - | $52.69M(+18.7%) |
| Mar 2024 | - | $44.38M(+12.0%) |
| Dec 2023 | $39.66M(+210.5%) | $39.63M(+39.7%) |
| Sep 2023 | - | $28.37M(+28.6%) |
| Jun 2023 | - | $22.05M(+25.9%) |
| Mar 2023 | - | $17.51M(+37.8%) |
| Dec 2022 | $12.77M(+412.8%) | $12.71M(+95.0%) |
| Sep 2022 | - | $6.52M(+42.7%) |
| Jun 2022 | - | $4.57M(-29.3%) |
| Mar 2022 | - | $6.46M(+158.3%) |
| Dec 2021 | $2.49M(+423.3%) | $2.50M(+305.0%) |
| Sep 2021 | - | $617.70K(+32.2%) |
| Jun 2021 | - | $467.20K(+562.7%) |
| Mar 2021 | - | $70.50K(-85.1%) |
| Dec 2020 | $476.00K(-47.1%) | $473.50K(-85.2%) |
| Sep 2020 | - | $3.19M(>+9900.0%) |
| Dec 2019 | $900.60K | $0.00(0.0%) |
| Sep 2019 | - | $0.00(0.0%) |
| Jun 2019 | - | $0.00(-100.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $4500.00(-34.8%) |
| Dec 2018 | $6900.00(-96.9%) | $6900.00(-71.7%) |
| Sep 2018 | - | $24.40K(+23.2%) |
| Jun 2018 | - | $19.80K(-52.6%) |
| Mar 2018 | - | $41.80K(-81.5%) |
| Dec 2017 | $225.50K(-25.7%) | $225.80K(-57.0%) |
| Sep 2017 | - | $524.90K(+2.3%) |
| Jun 2017 | - | $513.20K(+26.9%) |
| Mar 2017 | - | $404.30K(+33.6%) |
| Dec 2016 | $303.40K(-73.9%) | $302.70K(-35.7%) |
| Sep 2016 | - | $470.90K(+8.1%) |
| Jun 2016 | - | $435.50K(-57.0%) |
| Mar 2016 | - | $1.01M(-12.5%) |
| Dec 2015 | $1.16M(-26.0%) | $1.16M(+40.5%) |
| Sep 2015 | - | $822.70K(-45.2%) |
| Jun 2015 | - | $1.50M(-3.9%) |
| Dec 2014 | $1.57M(-33.3%) | $1.56M(+6.0%) |
| Sep 2014 | - | $1.48M(-48.6%) |
| Jun 2014 | - | $2.87M(+22.2%) |
| Dec 2013 | $2.35M(-68.9%) | $2.35M(-26.8%) |
| Sep 2013 | - | $3.21M(+170.4%) |
| Jun 2013 | - | $1.19M |
| Dec 2012 | $7.56M(+370.0%) | - |
| Dec 2011 | $1.61M | - |
FAQ
- What is Ascendis Pharma A/S annual accounts receivable?
- What is the all time high annual accounts receivable for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual accounts receivable year-on-year change?
- What is Ascendis Pharma A/S quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly accounts receivable year-on-year change?
What is Ascendis Pharma A/S annual accounts receivable?
The current annual accounts receivable of ASND is $173.03M
What is the all time high annual accounts receivable for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual accounts receivable is $173.03M
What is Ascendis Pharma A/S annual accounts receivable year-on-year change?
Over the past year, ASND annual accounts receivable has changed by +$133.37M (+336.33%)
What is Ascendis Pharma A/S quarterly accounts receivable?
The current quarterly accounts receivable of ASND is $129.65M
What is the all time high quarterly accounts receivable for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly accounts receivable is $172.18M
What is Ascendis Pharma A/S quarterly accounts receivable year-on-year change?
Over the past year, ASND quarterly accounts receivable has changed by +$76.96M (+146.07%)